Skip to Content

Engineering biology

capgemini-invent

Advances in Engineering Biology, sometimes known as synthetic biology, are unlocking a new industrial revolution to meet economic, environmental, and societal imperatives

What is Engineering biology? Engineering Biology is an emerging discipline of biotechnology with disruptive potential across all industries – whether addressing the climate crisis through biodegradable products and novel strategies for re-capturing carbon or enabling new drugs and therapies that unlock unparalleled levels of personalized medicine.

Also known as ‘synthetic biology,’ engineering biology leverages AI and other innovative technologies and processes to radically reduce the time and cost of realizing biotech solutions. From life sciences to manufacturing, pharmaceuticals to consumer goods, the applications for synthetic biology are helping leading organizations meet the moment in truly disruptive and awe-inspiring ways.

At Capgemini Invent, we have a highly unusual set of scientific, engineering, computational and advisory skills to help clients navigate the E2E process of creating and launching new BioSolutions.

“From practical biological development to scale-up engineering and advisory services, our biotech consulting experts can help your business realize sustainable, lasting transformation through synthetic biology methods and solutions, through the entire E2E process.”

Applications of synthetic biology

Across all industries, synthetic biology is changing the world in new and powerful ways.

Pharmaceuticals & medicine

Enabling new forms of advanced drug discovery and antibody production, tissue engineering, gene therapies, and diagnostics for more effective healthcare

Enabling the production of new and more sustainable biofuels like biodiesel and bioethanol that can reduce dependence on fossil fuels

Creating alternative solutions for materials like packaging, fabrics, and plastics, together with chemicals and ingredients, in areas like fertilizers, detergents, fragrances, and solvents with more sustainable footprints

Creating higher performance crops with more sustainable production and the ability to grow synthetic food and proteins in labs

Capturing carbon in new ways, creating biosensors that alert to the presence of pollutants, and offering approaches to clean/purify resources and chemical waste

How we can help: accelerating your bioeconomy journey

At Capgemini Invent we help clients successfully navigate the end-to-end journey, from creating a compelling new SynBio vision, to practical breakthrough biotech realization and commercial impact.

We guide visionary start-ups and large multinationals alike in driving a bioeconomy strategy. Our expertise spans ‘engineered’ synthetic biology, assay development, physical scale-up engineering, digital twinning and AI. Facilities include state-of-the-art, AI-driven synthetic biology labs, engineering facilities, and a server farm to solve the toughest technical and scientific challenges.

Additionally, our biotech consultants will help you explore opportunities, build business and sustainability cases, test feasibility, and manage your innovation budget and timescale for highest business impact.

Engineering Biology labs

Building on 10 years of pioneering engineering biology and AI development, Capgemini has created state-of-the-art AI-driven biotechnology labs, situated at the headquarters of Cambridge Consultants in the UK. Home to an unrivalled combination of multidisciplinary experts across biology, chemistry, engineering and data science, we have created innovative biosolutions such as a ‘plastic eating enzyme’, a DNA-based data storage machine and engineered nitrogen-fixing microbes for better seed shelf-life in agriculture. With deep synthetic biology expertise, we are particularly adept at making bio-engineering more predictable, and hence unlock viable business cases in sectors ranging from healthcare, through to consumer and industrial.

With our engineering biology lab and deep industry expertise, we are uniquely placed to help clients identify new opportunities, reduce cost and time to accelerate their bio-journey.

Synthetic biology

For more information about how you can implement Synthetic Biology to gain a competitive advantage, please fill out the form below and one of our Synthetic Biology experts will be in touch.

Synthetic biology beta Image

Accelerating the tech-driven bioeconomy

Explore our whitepaper on accelerating the tech-driven bioeconomy in collaboration with the World Economic Forum and published on their site

WEF Report Accelerating the Tech Driven BioEconomy book final version

Client stories

Meet our experts

synthetic biology

Richard Traherne

Head of Synthetic Biology and Next Frontiers at Capgemini Invent

Frances Metcalfe

Global head of Biotechnology at Cambridge Consultants, part of Capgemini Invent

Ian Taylor

Engineering Biology Expert at Cambridge Consultants, part of Capgemini Invent

Will Addison

Group Leader, AI, and Algorithms at Cambridge Consultants, part of Capgemini Invent

Sriya Mohanti

Sustainability Advisory at Capgemini Invent